Global Powered Morcellators Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Powered Morcellators market size was valued at US$ 335 million in 2025 and is forecast to a readjusted size of US$ 502 million by 2032 with a CAGR of 6.0% during review period.
Powered morcellation systems are a class of medical devices used in minimally invasive surgery that mechanically drive a rotating blade to fragment large tissue specimens for extraction through small incisions. Their core clinical value lies in addressing the central paradox of minimally invasive surgery—how to remove tissue significantly larger than the diameter of the access port. From a technological composition standpoint, these systems typically consist of a console, handpiece, rotating blade, and tissue collection apparatus. The blade rotates at high speed to create a cutting effect, while an integrated suction function collects the fragmented tissue into a sealed container. In gynecology, this technology is widely applied in laparoscopic hysterectomy and myomectomy, sparing patients the trauma of open surgery. However, the industry development trajectory of this product has been profoundly shaped by its unique safety risks: the safety alert issued by the U.S. FDA in 2014 triggered a global regulatory restructuring, warning that the use of electric morcellators in patients with undiagnosed uterine sarcoma could lead to dissemination of malignant cells within the peritoneal cavity, severely impacting patient outcomes. This event not only altered the clinical use patterns of the product but also fundamentally shaped the technological evolution pathways, market access standards, and competitive landscape of powered morcellation systems.
Market Development Opportunities and Key Drivers
On the regulatory front, in November 2025, China's National Medical Products Administration issued a revised version of the Medical Device Good Manufacturing Practice, imposing stricter lifecycle quality management requirements for high-risk surgical instruments, effective November 2026. Innovative products featuring enhanced safety designs will gain structural advantages under this standardized regulatory framework. On the technology innovation front, the maturation of contained tissue extraction systems is fundamentally addressing the core risk of tumor cell dissemination, with major U.S. healthcare institutions gradually resuming use of systems equipped with enclosed morcellation bags between 2024 and 2025, indicating clinical reacceptance of the technology following risk mitigation. On the payment side, the proliferation of ambulatory surgical models is prompting healthcare institutions to reevaluate equipment configuration strategies, positioning powered morcellation systems with integrated tissue extraction capabilities as key enablers for improving the operational efficiency of minimally invasive surgery centers.
Market Challenges and Risks
The FDA safety alert issued in 2014 has evolved from a short-term market shock into a long-term structural constraint, reflected in persistently fluctuating utilization rates. At the clinical level, surgeons' concerns regarding preoperative occult malignancy risks persist, leading to a shift toward manual morcellation or in-bag morcellation techniques for certain procedures. On the regulatory compliance front, between 2025 and 2026, the U.S. FDA's MAUDE adverse event database continued to record reports related to powered morcellation systems, including diminished cutting efficacy due to blade wear and intraoperative equipment failures leading to procedure abandonment. These persistent clinical use issues have caused regulators to maintain a cautious stance toward new product approvals, extending the value realization cycle from registration to clinical adoption. On the payment front, certain commercial insurers have implemented stricter prior authorization requirements for procedures utilizing these devices, indirectly affecting healthcare institutions' purchasing decisions.
Downstream Demand Trends
In the gynecology field, the refinement of preoperative risk assessment protocols is driving market evolution toward technological upgrades, with second-generation powered morcellation systems equipped with contained tissue extraction bags gaining more clinical validation opportunities at large medical centers and teaching hospitals, where academic influence serves as a critical catalyst for new technology dissemination. In the urology field, prostate tissue morcellation demand is demonstrating stable growth. In medical device procurement, the tender announcement for an IBS intrauterine morcellation system by Yangzhou Traditional Chinese Medicine Hospital in October 2024 indicates sustained demand for powered morcellation systems among Chinese healthcare institutions, with a preference for sole-source procurement of established brands that have already formed clinical use habits.
Regional Trends
In the North American market, under the FDA's stringent regulatory framework, market focus is shifting from traditional electric morcellators toward systems equipped with enclosed morcellation bags, with product use strictly limited to patient populations in whom malignancy has been thoroughly ruled out preoperatively. The European market demonstrates a differentiated trajectory, with domestic manufacturers such as Karl Storz in Germany continuously optimizing blade durability and suction system performance. Investigations into adverse events occurring between 2024 and 2025 identified material wear and operator error as primary contributing factors, rather than product design defects, supporting sustained utilization rates in this market. In the Asia-Pacific region, China's market demand is characterized by coexistence of installed base maintenance and new procurement, with large public hospitals maintaining stable purchases of imported premium brands, while the new Good Manufacturing Practice for Medical Devices will drive local manufacturers toward higher compliance standards.
This report is a detailed and comprehensive analysis for global Powered Morcellators market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Powered Morcellators market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Powered Morcellators market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Powered Morcellators market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Powered Morcellators market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Powered Morcellators
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Powered Morcellators market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Karl Storz, Applied Medical, Olympus, Richard Wolf, ConMed, B. Braun Aesculap, LiNA Medical, Purple Surgical, LocaMed, Hologic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Powered Morcellators market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Electric Morcellators
Pneumatic Morcellators
Hydraulic Morcellators
Market segment by Containment
Open Morcellation
Suction-Sealed Morcellation
Contained Morcellation
Market segment by Blade Design
Serrated Blade
Helical Blade
Market segment by Cutting Mechanism
Rotational Cutting
Reciprocating Cutting
Oscillating Cutting
Market segment by Application
Urology
Gynecological Conditions
Digestive Tract Conditions
Colorectal Conditions
Major players covered
Karl Storz
Applied Medical
Olympus
Richard Wolf
ConMed
B. Braun Aesculap
LiNA Medical
Purple Surgical
LocaMed
Hologic
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Powered Morcellators product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Powered Morcellators, with price, sales quantity, revenue, and global market share of Powered Morcellators from 2021 to 2026.
Chapter 3, the Powered Morcellators competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Powered Morcellators breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Powered Morcellators market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Powered Morcellators.
Chapter 14 and 15, to describe Powered Morcellators sales channel, distributors, customers, research findings and conclusion.